HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeting Taxanes to Castration-Resistant Prostate Cancer Cells by Nanobubbles and Extracorporeal Shock Waves.

Abstract
To target taxanes to castration-resistant prostate cancer cells, glycol-chitosan nanobubbles loaded with paclitaxel and docetaxel were constructed. The loaded nanobubbles were then combined with Extracorporeal Shock Waves, acoustic waves widely used in urology and orthopedics, with no side effects. Nanobubbles, with an average diameter of 353.3 ± 15.5 nm, entered two different castration-resistant prostate cancer cells (PC3 and DU145) as demonstrated by flow cytometry and immunofluorescence. The shock waves applied increased the amount of intracellular nanobubbles. Loading nanobubbles with paclitaxel and docetaxel and combining them with shock waves generated the highest cytotoxic effects, resulting in a paclitaxel GI50 reduction of about 55% and in a docetaxel GI50 reduction of about 45% respectively. Combined treatment also affected cell migration. Paclitaxel-loaded nanobubbles and shock waves reduced cell migration by more than 85% with respect to paclitaxel alone; whereas docetaxel-loaded nanobubbles and shock waves reduced cell migration by more than 82% with respect to docetaxel alone. The present data suggest that nanobubbles can act as a stable taxane reservoir in castration-resistant prostate cancer cells and shock waves can further increase drug release from nanobubbles leading to higher cytotoxic and anti-migration effect.
AuthorsFrancesca Marano, Letizia Rinella, Monica Argenziano, Roberta Cavalli, Francesca Sassi, Patrizia D'Amelio, Antonino Battaglia, Paolo Gontero, Ornella Bosco, Rossella Peluso, Nicoletta Fortunati, Roberto Frairia, Maria Graziella Catalano
JournalPloS one (PLoS One) Vol. 11 Issue 12 Pg. e0168553 ( 2016) ISSN: 1932-6203 [Electronic] United States
PMID28002459 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Drug Carriers
  • Taxoids
  • glycol-chitosan
  • Docetaxel
  • Chitosan
  • Paclitaxel
Topics
  • Antineoplastic Agents, Phytogenic (chemistry, pharmacology)
  • Apoptosis (drug effects)
  • Cell Line, Tumor
  • Cell Movement (drug effects)
  • Chitosan (chemistry)
  • Docetaxel
  • Drug Carriers (chemistry)
  • Drug Liberation (radiation effects)
  • High-Energy Shock Waves
  • Humans
  • Male
  • Nanostructures (chemistry)
  • Paclitaxel (chemistry, pharmacology)
  • Particle Size
  • Prostatic Neoplasms, Castration-Resistant (metabolism, pathology)
  • Taxoids (chemistry, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: